News
Scores from the LPGA Tour-Dow Championship 2025 Dow Championship on ThursdayMoriya Jutanugarn (Thailand)Eun-Hee Ji (Korea Republic)Sarah Kemp (Australia)Sophia Popov (Germany)Amelia Lewis (USA)Lydia K ...
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
Takeda stopped enrolling patients in the trial, again well short of its target, earlier this year. Like TAK-186, TAK-280 used Maverick’s prodrug technology to restrict activation to the tumor ...
Following a positive Phase 3 readout for rusfertide in Oncology in March 2025, the company anticipates a further two Phase 3 readouts in core therapeutic areas this fiscal year. Takeda chief ...
OSAKA, Japan, May 08, 2025--Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2024 (period ended March 31, 2025) with continued strong momentum in Growth & Launch ...
Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches. Skip to content. Home page Seeking Alpha - Power to Investors.
Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook.
The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...
Global biopharmaceutical giant Takeda opens its first Asian Innovation Capability Centre in Bengaluru to speed-up drug discovery and development.
Jon Pareles. A Little Strife, a Lot of Rhythm. Here’s a dipperful of worthwhile tracks from the ocean of music released this year. The top of my list is big-statement songs, ones that had ...
Takeda’s FY2023 Financial Highlights (Data collected by the author from Takeda’s FY2023 report) In terms of debt, the company reported a 10.9% increase in net debt.
Pharmaceutical giant Takeda is shutting down its research and development hub in San Diego that employs 324 as part of a broader restructuring of the business. “This site closure is primarily a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results